C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/12 (2006.01) A61K 31/536 (2006.01)
Patent
CA 2680173
The present invention relates generally to pharmaceutical agents containing a heterocyclic moiety, and in particular, to heterocyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterocyclic MMP-13 inhibiting compounds with a benzoxazinone moiety, that exhibit an increased potency and selectivity in relation to currently known MMP-13 inhibitors.
De manière générale, l'invention concerne des agents pharmaceutiques contenant une fraction hétérocyclique, et en particulier, des composés inhibiteurs de métalloprotéase hétérocycliques. Plus particulièrement, la présente invention fournit une nouvelle catégorie de composés inhibiteurs de MMP-13 hétérocycliques pourvus d'une fraction de benzoxazinone, qui présentent une efficacité et une sélectivité accrues par rapport aux inhibiteurs de MMP-13 actuellement connus.
Bluhm Harald
Chevrier Carine
Gege Christian
Hochgurtel Matthias
Schneider Matthias
Alantos Pharmaceuticals Holding Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Metalloprotease inhibitors containing a heterocyclic moiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metalloprotease inhibitors containing a heterocyclic moiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloprotease inhibitors containing a heterocyclic moiety will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2057701